Journal article
Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta‐analysis
Abstract
BACKGROUND: In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these options as reducing relapses, their relative benefit and safety profiles remain unclear due to a lack of direct comparison trials.
OBJECTIVES: To compare through network meta-analysis the efficacy and safety of alemtuzumab, azathioprine, …
Authors
Ridley B; Minozzi SM; Gonzalez-Lorenzo M; Del Giovane C; Piggott T; Filippini G; Peryer G; Foschi M; Tramacere I; Baldin E
Journal
Cochrane Database of Systematic Reviews, Vol. 2025, No. 9,
Publisher
Wiley
DOI
10.1002/14651858.cd015443.pub2
ISSN
1361-6137